Authors
Pascal Amedro, Arthur Gavotto, Antoine Legendre, Kathleen Lavastre, Charlene Bredy, Gregoire De La Villeon, Stefan Matecki, Manon Ladeveze, Fanny Bajolle, Gilles Bosser, Helene Bouvaist, Philippe Brosset, Laurence Cohen, Sarah Cohen, Sonia Corone, Claire Dauphin, Yves Dulac, Sebastien Hascoet, Xavier Iriart, Magalie Ladouceur, Loic Mace, Oxana-Anca Neagu, Caroline Ovaert, Marie-Christine Picot, Laurent Poirette, Frederique Sidney, Camille Soullier, Jean-Benoit Thambo, Nicolas Combes, Damien Bonnet, Sophie Guillaumont
Publication date
2019/5/15
Journal
International journal of cardiology
Volume
283
Pages
112-118
Publisher
Elsevier
Description
Background
Advances in congenital heart disease (CHD) have transferred the mortality from childhood to adulthood. Exercise capacity in young patients with CHD remains lower than in the general population, resulting in deconditioning and impaired quality of life. Evidence based-medicine in cardiac rehabilitation in this age group with CHD remains limited. We present the QUALI-REHAB study rationale, design and methods.
Methods
The QUALI-REHAB trial is a nationwide, multicentre, randomised, controlled study, aiming to assess the impact of a combined centre and home-based cardiac rehabilitation program on the quality of life of adolescents and young adults (13 to 25 years old) with CHD. Patients with a maximum oxygen uptake (VO2max) < 80% and/or a ventilatory anaerobic threshold (VAT) < 55% of predicted VO2max, will be eligible. Patients will be randomised into 2 groups (12-week cardiac …
Scholar articles
P Amedro, A Gavotto, A Legendre, K Lavastre, C Bredy… - International journal of cardiology, 2019